middle.news
OncoSil Medical Secures Groundbreaking TGA Approval for Pancreatic Cancer Device
9:17am on Wednesday 20th of May, 2026 AEST
•
Healthcare
Read Story
OncoSil Medical Secures Groundbreaking TGA Approval for Pancreatic Cancer Device
9:17am on Wednesday 20th of May, 2026 AEST
Key Points
TGA approval for OncoSil™ device in pancreatic cancer
First Class III device targeting pancreatic tumours in Australia
4,353 new pancreatic cancer cases annually in Australia
New Sydney manufacturing facility nearing completion
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Oncosil Medical (ASX:OSL)
OPEN ARTICLE